Will Your Savings Survive the August 31st Debt Ceiling Crisis?

On Aug 31, the U.S. runs out of "extraordinary measures" to avoid default. Insiders are moving into crisis-proof assets-while everyday Americans risk losing big. The FREE Mar-A-Lago Accord reveals where they're hiding wealth, how the Fed's response could crush the dollar, and 3 urgent moves to make now.

Sanofi ADR
NASDAQ:SNY
$49.48
Open 49.43 Prev Close 49.94
High 49.74 Low 49.25
Volume 2,437,369 Volume (Avg) 2,263
52 Week High 57.57 52 Week Low 43.86
Market Cap 120.4B PE Ratio 12.35

General

NameSanofi ADR
TickerSNY
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - General
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees82,878

About Sanofi ADR

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, yellow fever, and rabies vaccines. In addition, the company has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Innate Pharma SA for a natural killer cell engager program targeting B7-H3; and Blackstone Life Sciences to develop pivotal studies and clinical development program. Further, it has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop novel targeted protein degradation therapies; Denali Therapeutics Inc. to treat a range of systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for the discovery and development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab, as well as an strategic alliance with the Department of Health " Abu Dhabi for the development of global vaccines. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incor

Highlights

Analyst Target62.28
Market Cap120,415,500,000
PE Ratio12.35
PEG Ratio0.86
EBITDA12,081,999,872

Valuation

Trailing PE16.65
Forward PE11.15
Price/Sales (Trailing 12 Mt.)2.67
Price/Book (Most Recent Quarter)1.50

Technicals

Beta0.51
52 Week High57.57
52 Week Low43.86
50 Day Average1.45%
200 Day Average-3.02%

Dividend

Sanofi ADR pays out a dividend of $2.39 per share, with a dividend yield of 4.82%.

SNY's last dividend payment was made to shareholders on June 12, 2025.

They pay out 66.53% of their earnings out as a dividend.

Recent Dividends

Jun 12, 2025$2.21
Jun 6, 2024$2.04
Most Popular

Trump's new CDC chief: A Washington health insider with a libertarian streak

WASHINGTON (AP) — President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency's director was forced out.

Lawsuit challenges Hawaii's tourist tax on cruise industry aimed at climate change consequences

HONOLULU (AP) — A lawsuit challenging the constitutionality of Hawaii imposing a to deal with climate change consequences seeks to stop officials from enforcing the new law on cruise ship passengers.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

AT&T's $17 Million Data Breach Settlement Offers Payouts Up To $7,500, Here's How To Claim

AT&T customers, both present and past, stand to receive up to $7,500 as part of a proposed $177 million settlement. This settlement is in response to two significant data breaches that affected millions of AT&T customers.

Gold Is Soaring. Here's How To Get Paid From It - Ad

Gold just broke through $3,300. And while the headlines shout about price targets, something even more powerful is happening behind the scenes. Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. Just a simple fund delivering monthly payouts.

Trump Tariffs Likely To Be Struck Down As 'Unconstitutional' In Appellate Court, Says Peter Schiff: Handing The President 'Another Scapegoat'

Economist Peter Schiff says that President Donald Trump's tariffs are likely headed for defeat at the U.S. Appellate Court, setting the stage for what he refers to as "another scapegoat" for the coming recession.

Billionaire Investor Buys Google And This Gold Miner Stock

John Paulson's hedge fund discloses the purchase of 9,000 shares of Alphabet.

Your Entire Portfolio is Dangerously Exposed... - Ad

Alex Green, who spotted Nvidia at $1.10 per share split-adjusted, now says he believes 7 AI stocks are set to explode. These aren't meme plays or crypto gambles - they're real companies with trillion-dollar potential in the coming years. Act before Wall Street catches on... or risk Googling "what to do with my fortune" at 3 a.m.

How To Earn $500 A Month From Walmart Stock Ahead Of Q2 Earnings

Walmart offers a quarterly dividend amount of 23 cents per share. To earn $500 monthly, start with the yearly target of $6,000.

Epstein accuser Virginia Giuffre wrote a memoir. Months after her death, it's coming out

NEW YORK (AP) — A posthumous and “unsparing” memoir by one of most prominent accusers, will be published this fall, publishing house Alfred A. Knopf said Sunday.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.

Palantir CEO Alex Karp Dumps $63 Million In Stock As PLTR Surges 111% This Year

Palantir CEO Alex Karp sold $62.7 million in stock amid rising valuation concerns and insider selling pressure, even as the stock remains up 397% year-over-year.

Trump's Moves Push Intel To Strongest Week In 25 Years

Intel stock heads for its best week since January 2000 driven by vocal support from President Donald Trump. 

Discover the AI Stock 6 Tech Giants Bought - Ad

If you'd put $7K into the original "Magnificent Seven" stocks 20 years ago, you'd have $1.18M today. Now, the investor who called Nvidia at $1.10 per share split-adjusted has found the next seven potential winners - including one stock backed by Apple, Nvidia, Google, Samsung & Intel, with tech in 280B+ devices and long-term deals set up until 2040.

Las Vegas tourism is down. Some blame Trump's tariffs and immigration crackdown

LAS VEGAS (AP) — Tourism in Las Vegas is slumping this summer, with resorts and convention centers reporting fewer visitors compared to last year, especially from abroad, and some officials are blaming the Trump administration’s and policies for the decline.

Cuban Has Resisted Presidential Run, but Says a Trump Third-Term Bid Could Draw Him Into the Race

Mark Cuban has resisted calls to run for president, but recently said that any effort by President Trump to seek a third term could drawn him into the race.

How 433 Investors Unlocked 400X Return Potential - Ad

VCs back startups for outsized gains. Regular investors wait. But rule changes fixed that. Take Revolut. In 2016, 433 people averaged a $2,370 stake. Today? It's worth $1M+, up 89,900%. No wonder 10K+ people and the VCs behind Uber and eBay took the chance on Pacaso's $1.3T market disruption.

Hijacked satellites and orbiting space weapons: In the 21st century, space is the new battlefield

WASHINGTON (AP) — As Russia held its this year, hackers backing the Kremlin hijacked an orbiting satellite that provides television service to Ukraine.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Microsoft reviewing Israeli military's use of its tech amid worker protests

REDMOND, Wash. (AP) — Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the Israeli military's use of its technology during the .

ETHZilla Rebrands From 180 Life Sciences, But Stock Sinks 4% In After-Hours Trading: Here's Why

Shares of the newly branded ETHZilla Corp. (NASDAQ:ETHZ) sank over 4% in Monday's after-hours trading amid a dip in Ethereum (CRYPTO: ETH), its primary treasury asset.

"Forget AI" Says Reagan's No. 1 Futurist - Ad

While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.

Trump 2.0 At 200 Days: Palantir Surges, Tesla Slumps

Palantir leads all stocks in the S&P 500 with a stunning 160% gain in Trump's first 200 days. 

Futurist Eric Fry Says It Will Be a "Summer of Surge" for These Three Stocks - Ad

One company to replace Amazon... another to rival Tesla... and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Elizabeth Warren Slams 'Chaotic Tariff Policies' For Skyrocketing Wholesale Vegetable Prices: You Can Thank Donald Trump

Sen. Elizabeth Warren (D-MA) is criticizing President Donald Trump's trade and tariff policies over a sharp rise in wholesale vegetable prices in recent weeks.

Will Your Savings Survive the August 31st Debt Ceiling Crisis? - Ad

On Aug 31, the U.S. runs out of "extraordinary measures" to avoid default. Insiders are moving into crisis-proof assets-while everyday Americans risk losing big. The FREE Mar-A-Lago Accord reveals where they're hiding wealth, how the Fed's response could crush the dollar, and 3 urgent moves to make now.

Nike co-founder Phil Knight and wife pledge record $2B to Oregon cancer center, university says

PORTLAND, Ore. (AP) — co-founder Phil Knight and his wife Penny Knight have pledged to donate $2 billion to Oregon Health & Science University’s Knight Cancer Institute, the school announced Thursday, describing it as the largest single gift to a U.S. university.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

USA Rare Earth Q2 FY2025 Earnings Call Transcript

USA Rare Earth reported Q2 earnings, aiming to build a profitable and integrated supply chain for rare earths. Focus on mining, processing, recycling and serving diverse customers.

'Make Cracker Barrel Great Again': Donald Trump, Republican Party Weigh In On Restaurant Logo Rebrand

A logo rebrand by Cracker Barrel may divide the nation with conservatives ready to boycott the restaurant. President Trump shares his advice.

Gold Is Soaring. Here's How To Get Paid From It - Ad

Gold just broke through $3,300. And while the headlines shout about price targets, something even more powerful is happening behind the scenes. Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. Just a simple fund delivering monthly payouts.

Democrats ask Trump to resume a major offshore wind project near Rhode Island

A nearly complete wind farm off the coast of Rhode Island and Connecticut faces an uncertain future as the states' Democratic governors, members of Congress and union workers are calling Monday for the Trump administration to let construction resume.

Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter

Elliott Management places new bets against the market in the second quarter, while taking a new long position in Hewlett Packard Enterprise.

Your Entire Portfolio is Dangerously Exposed... - Ad

Alex Green, who spotted Nvidia at $1.10 per share split-adjusted, now says he believes 7 AI stocks are set to explode. These aren't meme plays or crypto gambles - they're real companies with trillion-dollar potential in the coming years. Act before Wall Street catches on... or risk Googling "what to do with my fortune" at 3 a.m.

Cracker Barrel unveils a new logo as part of wider rebrand efforts, sparking ire among some online

NEW YORK (AP) — Cracker Barrel is marching forward with an ongoing makeover. And to the dismay of some fans, the chain's new logo now ditches the barrel itself.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright smartmoneytrading.net
Privacy Policy | Terms of Service